Biobeat
AI remote patient monitoring platform, measuring 13 vital signs and triggering early clinical intervention
35 employees · est. 2016 · Israel
Global Blood Therapeutics is the older company (2016 vs 2011); Global Blood Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Biobeat | Global Blood Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2011 older |
| Headquarters | ||
| Headquarters | Israel | South San Francisco, United States |
| Employees | ||
| Employees | 35 | 100 larger |
| Industry | ||
| Industry | Biotechnology, Data Analytics, Hardware | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Post Ipo Debt |
| Total Funding | ||
| Total Funding | $8.00M | $969.50M |
| Funding Rounds | ||
| Funding Rounds | 2 | 7 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Remote Patient Monitoring, AI Healthcare, Wearable Devices, FDA Clearance, Biometric Monitoring, Medical Data Analytics, Cloud-based Patient Management, Non-invasive Monitoring, Vital Sign Monitoring, Patient Care Technology, Medical-grade Sensors, HIPAA Compliance, GDPR Compliance | Biopharmaceutical, Clinical-stage, Sickle Cell Disease, Treatment Innovation, Patient Community Focus, Voxelotor, Oral Therapy, San Francisco, California, Drug Development, Pfizer Acquisition, Medical Research, Underserved Patient Support |
| Website | ||
| Website | bio-beat.com | gbt.com |
About Biobeat
Biobeat Analysis Biobeat is an Israeli-based med-tech startup founded in 2016, specializing in remote patient monitoring with its distinct health-AI technology. The company's AI remote patient monitoring platform measures 13 vital signs and triggers early clinical intervention. Biobeat's innovative...
About Global Blood Therapeutics
Global Blood Therapeutics (GBT) is a biotechnology company founded in 2011 and based in the United States. Most recently, the company received a significant $300.00M Post-IPO Debt investment on 15 December 2021. GBT's dedication to addressing the unmet needs of individuals living with sickle cell di...
We will tell you when either one moves
BounceWatch watches Biobeat and Global Blood Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Biobeat and Global Blood Therapeut... — by email.
Frequently Asked Questions
Compare Biobeat with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Biobeat on 12 Sep 2024, and Global Blood Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
